|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 24, No 25 (September 1), 2006: pp. 4209-4213 © 2006 American Society of Clinical Oncology. DOI: 10.1200/JCO.2006.06.007
Discussing Prognosis: "How Much Do You Want to Know?" Talking to Patients Who Are Prepared for Explicit Information
From the University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA; and the Institute for Doctor-Patient Communication, University of Pittsburgh, Pittsburgh, PA Address reprint requests to Anthony Back, MD, Seattle Cancer Care Alliance, 825 Eastlake Avenue E, PO Box 19023, Seattle, WA 98109-1023; e-mail: tonyback{at}u.washington.edu HERES THE CASE Mrs D, a 57-year-old woman with metastatic pancreatic cancer, is discussing treatment options with Dr B. How much should I tell her about prognosis? he wonders. She already seems nervous. Do I hand her the death sentence? Or sugarcoat the statistics? Maybe I'll wait to see if she asks. For the first time Mrs D looks up and says, "What should I expect?" Dr B balks, not having decided what to say. "Umm, I can't really predict," he mumbles. "Every patient is different." Perhaps I am mumbling, thinks Dr B, because I'm not telling her the whole truth. Mrs D nods vaguely without meeting his gaze and picks up her purse to leave. Is she dissatisfied also? Dr B finds himself in a familiar dilemma: how much information should an oncologist give about a bad prognosis? One of his colleagues prides himself on being a realist, "I tell patients the truth because they need to know, whether they want to hear it or not." Another colleague feels he must give hope, "I go into cheerleader mode." Neither alternative seems optimal to Dr B—the nurses tell him that the realist tone is a little brutal, and that the cheerleader is more than a little clueless. Privately, Dr B feels his own practice—avoiding prognosis by emphasizing individual differences—borders on disingenuous. He knows a lot more about what will happen to Mrs D than he is letting on. Realism, optimism, and avoidance are the most common strategies physicians use in discussing prognosis.1 Although these strategies are well intended and commonly used, they also create unintended consequences. In this article, a patient-centered method for disclosing prognosis is proposed and illustrated. The method builds on existing empirical evidence about discussing prognosis2,3 by drawing on principles of negotiation and patient-centered approaches. This approach enables an oncologist to figure out what kind of prognostic information to disclose with a particular patient at a particular time and how to individualize the discussion. This article describes how the approach works with a patient who is ready for an explicit discussion. STRATEGIES WITH UNINTENDED CONSEQUENCES: REALISM, OPTIMISM, AVOIDANCE Commonly used, none of these strategies are completely satisfactory, but each has useful features. The useful feature of realism is that prognostic information helps patients and physicians to make sound medical decisions. Both bioethical reasoning and empirical evidence support the importance of accurate patient understanding of prognosis.4 Yet patients also report that realistic prognostic discussions can be blunt and sometimes brutal.5 A physician who presents prognosis realistically, but without structuring the conversation before the information or responding empathetically afterwards, can be perceived as uncaring. Moreover, empirical data suggest that roughly 20% of patients, particularly those with advanced, metastatic disease, do not want complete information about their prognosis.6-8 Giving these patients realistic information may cause psychological harm, although there are not empirical studies that address this question. Optimism can play a useful role in supporting a patient's hopes and many patients report that they want a doctor who is hopeful.9,10 In discussions about prognosis, however, physicians who deliberately exaggerate or overemphasize optimistic information may risk losing the trust of patients who later discover that the information they received was not entirely true.11 Moreover, patients whose are overly optimistic about their chances of survival are more likely to choose life-sustaining therapies in the last 6 months of life12—often when these therapies are least effective. These patients, who sometimes frustrate their physicians in their pursuit of futile therapy, may lose opportunities to arrange their lives to maximize their time with loved ones, plan their financial affairs, and work toward life closure.13 A third strategy is to avoid prognostication altogether, often by emphasizing individual differences, unpredictability of disease course, or exceptional outliers. Collusion is a variation of this strategy in which physicians avoid providing realistic information by creating a tacit understanding that neither patient nor physician will bring up the topic.14,15 Avoidance is based on reasonable concerns. First, physicians realize that they are often inaccurate when predicting survival for an individual.16 Second, physicians worry that discussing survival communicates a subtle psychological message that a patient will die at a given time.9 Third, physicians find that some patients do not want prognostic information. Finally, physicians find that bad news often causes patient distress.17 Yet physicians who avoid prognostication may seem evasive, and consequently untrustworthy, especially when studies indicate that many patients want to talk about life expectancy.2 While it is clear that discussing prognosis can be stressful, the fact that the news is unpleasant is not a sufficient reason to avoid it. Personal experience shows that many patients want to know their prognosis, even though they are upset by knowing it. Thus, for some physicians, the useful aspect of avoidance is that it limits their own exposure to patient distress. In the opening example, Dr B avoided a discussion that he anticipated would be difficult, and Mrs D took away a tacit understanding that prognosis was an issue that he was either unable or unwilling to address. Dr B missed an important opportunity. A BETTER ALTERNATIVE: HOW MUCH DO YOU WANT TO KNOW? The approach proposed for discussing prognosis is based on work in negotiation and patient-centered communication and the research available on what patients want to know about prognosis. In addition to the finding that most patients (at least 80% in most studies) want detailed information, surveys demonstrate that there are many different possible prognostic questions that could be answered.3,8 A qualitative study concluded that physicians can provide the right amount of information for a particular patient only after eliciting that patient's goals and values.18 Yet none of these studies outline an approach that enables a physician to decide how much and what kind of prognostic information to tell a particular patient. To develop a stepwise approach, this current proposal draws on negotiation techniques19,20 and principles of patient-centered communication21-23 for ways to handle communication processes that involve complex back-and-forth transactions. Discussing prognosis is more complex than other communication tasks, such as giving bad news, because it requires a synthesis of communication skills and biomedical content knowledge. This current approach assumes that physicians are comfortable with fundamental communication skills, such as detecting emotions, responding empathetically, and eliciting patient understanding.21,22 The approach also assumes that the physician is prepared to discuss the relevant biomedical literature describing prognosis for the illness in question.24 THE OPENING QUESTION: HOW MUCH DO YOU WANT TO KNOW ABOUT PROGNOSIS? Because studies show that a majority of patients want to discuss prognosis, it is recommended that physicians ask explicitly how patients want to talk about prognosis. Because many patients may not understand the term prognosis, an alternative is to ask, "How much do you want to know about the likely course of this illness?" These questions invite a response that goes beyond yes or no. A physician could even normalize a range of patient interest: "Some people want lots of details, some want the big picture, and others prefer that I talk to their family. What would be best for you?" There are three kinds of answers to this question: the patient (1) wants information; (2) does not want information; (3) is ambivalent. Occasionally the patient will say that they want a lot of information, and yet their body language will contradict them. A patient who says "yes" but is hesitating, looking down, shifting in his seat, or has a facial expression indicating distress may also be saying "no" nonverbally. Paralanguage—umms, aahs, or silences—may signal thinking or hesitation, or discomfort and can be explored directly. These nonverbal cues are extremely helpful since they are under less conscious control, but they are also more ambiguous than verbal responses. The principle here is, if you have a hunch, you should explore it: "I notice you are hesitating...are you having other thoughts about this?" Or, "Is this a difficult issue for you to talk about?" The rest of this article describes how to deal with patients who seem ready for an explicit discussion. How to discuss prognosis with patients who do not want information or those who are ambivalent is addressed in a separate article.25 FOR PATIENTS WHO WANT INFORMATION After the opening question, we suggest the following steps. The principle underlying this kind of discussion is that patients are more likely to try to understand and retain information they want.
Negotiate the Content of the Discussion
Provide the Information
Acknowledge the Patient's and Families' Reactions to the News Explicitly
Check for Understanding A sample conversation with a patient who is interested in information is shown in Table 1, and a follow-up conversation with the same patient is shown in Table 2.
IS THE APPROACH WORKING? Physicians often rely on their impression of a conversation to know whether they have communicated effectively, yet studies indicate the self-evaluation is not always accurate. A more effective way to judge the effectiveness of a discussion about prognosis is to check-in with the patient during the conversation. For example, a physician might say, "Do you want to keep talking about this?" Or, "Am I giving you the kind of information you wanted?" Or, at the end of a conversation, "Have you have received the information you need?" While these questions may seem similar to the Checking for Understanding step, these questions are meant to focus on the process of the conversation rather than the accuracy of information delivery. Real success in discussing prognosis means engaging the patient in a process of growing understanding about their situation, understanding the patient's evolving information needs, and providing the information in a way that the patient can understand it. CONCLUSION Commonly used strategies for disclosing prognosis, including realism, optimism, and avoidance, have unintended consequences that do not always serve patients, family members, and physicians. Asking patients how much they want to know can facilitate an explicit discussion that meets individual patient needs. These patients may want to know information about their prognosis even if it is disappointing or upsetting. This approach provides a framework that oncologists can use to align themselves with their patients and guide patients toward sound medical decisions in the midst of difficult circumstances. Authors' Disclosures of Potential Conflicts of Interest The authors indicated no potential conflicts of interest.
ACKNOWLEDGMENTS We acknowledge National Cancer Institute Grant No. R25 92055, their Oncotalk colleagues Walter Baile, MD, Kelly Fryer-Edwards, PhD, and James Tulsky, MD, and all the oncologists who have participated in the Oncotalk retreats. NOTES Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article. REFERENCES
1. Lamont EB, Christakis NA: Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med 134:1096-1105, 2001 2. Clayton JM, Butow PN, Tattersall MH: When and how to initiate discussion about prognosis and end-of-life issues with terminally ill patients. J Pain Symptom Manage 30:132-144, 2005[CrossRef][Medline] 3. Hagerty RG, Butow PN, Ellis PM, et al: Communicating prognosis in cancer care: A systematic review of the literature. Ann Oncol 16:1005-1053, 2005 4. Christakis NA: Death Foretold: Prophecy and Prognosis in Medical Care. Chicago, IL, University of Chicago Press, 2000 5. Curtis JR, Wenrich MD, Carline JD, et al: Patients' perspectives on physician skill in end-of-life care: Differences between patients with COPD, cancer, and AIDS. Chest 122:356-362, 2002 6. Fried TR, Bradley EH, O'Leary J: Prognosis communication in serious illness: Perceptions of older patients, caregivers, and clinicians. J Am Geriatr Soc 51:1398-1403, 2003[CrossRef][Medline] 7. Leydon GM, Boulton M, Moynihan C, et al: Faith, hope, and charity: An in-depth interview study of cancer patients' information needs and information-seeking behavior. West J Med 173:26-31, 2000[CrossRef][Medline] 8. Jenkins V, Fallowfield L, Poole K: Information needs of patients with cancer: Results from a large study in UK cancer centres. Br J Cancer 84:322-331, 2001 9. Delvecchio Good MJ, Good BJ, Schaffer C, et al: American oncology and the discourse on hope. Cult Med Psychiatry 14:59-79, 1990[CrossRef][Medline] 10. Clayton JM, Butow PN, Arnold RM, et al: Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer 103:1965-1975, 2005[CrossRef][Medline] 11. Fallowfield LJ, Jenkins VA, Beveridge HA: Truth may hurt but deceit hurts more: Communication in palliative care. Palliat Med 16:297-303, 2002 12. Weeks JC, Cook EF, O'Day SJ, et al: Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 279:1709-1714, 1998 13. Quill TE: Perspectives on care at the close of life. Initiating end-of-life discussions with seriously ill patients: Addressing the "elephant in the room". JAMA 284:2502-2507, 2000 14. The AM, Hak T, Koeter G, et al: Collusion in doctor-patient communication about imminent death: An ethnographic study. BMJ 321:1376-1381, 2000 15. Helft PR: Necessary collusion: Prognostic communication with advanced cancer patients. J Clin Oncol 23:3146-3150, 2005 16. Christakis NA, Lamont EB: Extent and determinants of error in doctors' prognoses in terminally ill patients: Prospective cohort study. BMJ 320:469-472, 2000 17. Schofield PE, Butow PN, Thompson JF, et al: Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol 14:48-56, 2003 18. Hagerty RG, Butow PN, Ellis PM, et al: Communicating with realism and hope: Incurable cancer patients' views on the disclosure of prognosis. J Clin Oncol 23:1278-1288, 2005 19. Stone D, Patton B, Heen S: Difficult Conversations: How to Discuss What Matters Most. New York, NY, Penguin Putnam, 2000 20. Back AL, Arnold RM: Dealing with conflict in caring for the seriously ill: "It was just out of the question." JAMA 293:1374-1381, 2005 21. Kurtz SM, Silverman J, Draper J: Teaching and Learning Communication Skills in Medicine. London, United Kingdom, Radcliffe Publications, 2005 22. Back AL, Arnold RM, Baile WF, et al: Approaching difficult communication tasks in oncology. CA Cancer J Clin 55:164-177, 2005 23. Lipkin M, Putnam SM, Lazare A: The Medical Interview: Clinical Care, Education, and Research. New York, NY, Springer-Verlag, 1995 24. Epstein RM, Alper BS, Quill TE: Communicating evidence for participatory decision making. JAMA 291:2359-2366, 2004 25. Back AL, Arnold RM: Discussing prognosis: "How much do you want to know?" Talking to patients who do not want information or are ambivalent. J Clin Oncol 24:4214-4217, 2006 26. Groopman JE: A strategy for hope: A commentary on necessary collusion. J Clin Oncol 23:3151-3152, 2005
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|